SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-000892
Filing Date
2018-02-22
Accepted
2018-02-22 07:17:43
Documents
106
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 20-F rdhl-20171231x20f.htm 20-F 4180368
2 EX-1.1 rdhl-20171231ex11d229f99.htm EX-1.1 277362
3 EX-4.14 rdhl-20171231ex414d74128.htm EX-4.14 297751
4 EX-4.19 rdhl-20171231ex419d714b2.htm EX-4.19 365159
5 EX-4.20 rdhl-20171231ex420927b3a.htm EX-4.20 241834
6 EX-4.5 rdhl-20171231ex45c2953eb.htm EX-4.5 24371
7 EX-4.6 rdhl-20171231ex460f69c5e.htm EX-4.6 30662
8 EX-8.1 rdhl-20171231ex819380bfc.htm EX-8.1 8701
9 EX-12.1 rdhl-20171231ex1211cbb96.htm EX-12.1 20879
10 EX-12.2 rdhl-20171231ex122f13d02.htm EX-12.2 18202
11 EX-13 rdhl-20171231ex13d375c6c.htm EX-13 12110
12 EX-15.1 rdhl-20171231ex151813c99.htm EX-15.1 7824
13 GRAPHIC rdhl20171231ex151813c99001.jpg GRAPHIC 3577
14 GRAPHIC rdhl20171231ex414d74128001.jpg GRAPHIC 3665
15 GRAPHIC rdhl20171231ex414d74128002.jpg GRAPHIC 5917
16 GRAPHIC rdhl20171231x20f001.jpg GRAPHIC 3644
  Complete submission text file 0001558370-18-000892.txt   12730924

Data Files

Seq Description Document Type Size
17 EX-101.INS rdhl-20171231.xml EX-101.INS 2334890
18 EX-101.SCH rdhl-20171231.xsd EX-101.SCH 83771
19 EX-101.CAL rdhl-20171231_cal.xml EX-101.CAL 56806
20 EX-101.DEF rdhl-20171231_def.xml EX-101.DEF 198556
21 EX-101.LAB rdhl-20171231_lab.xml EX-101.LAB 577135
22 EX-101.PRE rdhl-20171231_pre.xml EX-101.PRE 410703
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 20-F | Act: 34 | File No.: 001-35773 | Film No.: 18630558
SIC: 2834 Pharmaceutical Preparations